References
- Haiper RA, Jackson DC. Progressive systemic sclerosis. Br J Radiol 1965: 38: 825–34
- Poirier TJ. Rankin GB. Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases. Am J Gastroenterol 1972: 58: 30–44
- Treacy WL. Baggenstoss AH. Slocumb CH. et al. Scleroderma of the esophagus: a correlation of histologic and physiologic findings. Ann Intern Med 1963: 59: 351–6
- Atkinson M, Summerling MD. Oesophageal changes in systemic sclerosis. Gut 1966: 7: 402–8
- Cohen S, Fisher R, Lipshutz W. et al. The pat ho genesis of esophageal dysfunction in scleroderma and Raynaud's disease. J Clin Invest 1972: 51: 2663–8
- Hoskins LC, Norris HT. Gottlieb LS, et al. Functional and morphologic alterations of the gastrointestional traci in progressive systemic sclerosis (scleroderma). Am J Med 1962: 33: 459–70
- Bluestone R, Macmahon M, Dawson JM. Systemic sclerosis and small bowel Involvement. Gut 1969: 10: 185–93
- Greenberger NJ, Dobbins WO 3d, Ruppert RD, et al. intestinal atony in progressive systemic sclerosis (scleroderma). Am J Med 1968: 45: 301–8
- Cohen S. The gastrointestinal manifestations of scleroderma: pathogenesis and management. Gastroenterology 1980: 79: 155–66
- Drasar BS. Hill MJ, Shiner M. The deconjugation of bile salts by human intestinal bacteria. Lancet 1966;1: 1237–8
- Salen G. Goldstein F, Wirts CW. Malabsorption in intestinal scleroderma: relation to bacterial flora and treatment with antibiotics. Ann Intern Med 1966: 64: 834–41